Skip to main content
NIH funding notice RFA-AR-17-003

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)

Closed on April 3, 2017.

Posted
February 5, 2016
Close date
April 3, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $863,676 in first-year total cost, median $431,838.

Most frequent study sections

  1. Special Emphasis Panel[ZAR1 XZ (M1)]1
  2. Special Emphasis Panel[ZAR1 YL (M3)]1

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. OKLAHOMA MEDICAL RESEARCH FOUNDATION1
Competing awards under RFA-AR-17-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation1R01AR072401-01JAMES, JUDITH AOKLAHOMA MEDICAL RESEARCH FOUNDATION, OK$460,680ZAR1
2017Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency1R01AR071741-01LEE, BRENDANNAGAMANI, SANDESH CHAKRAVARTHY SREENATHBAYLOR COLLEGE OF MEDICINE, TX$402,996ZAR1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AR-17-003: Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01) | ScienceDex | ConductScience